Terumo Corp. (OTCMKTS:TRUMY) Stock Short Interest Jumps 150.5%

Terumo Corp. (OTCMKTS:TRUMY – Get Free Report) was the target of a large increase in short interest during the month of October. As of October 30th, there was short interest totaling 54,335 shares, an increase of 150.5% from the October 15th total of 21,689 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 428,051 shares, the days-to-cover ratio is currently 0.1 days.

Analyst Upgrades and Downgrades

TRUMY has been the topic of several recent research reports. Nomura upgraded shares of Terumo from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. Zacks Research upgraded shares of Terumo from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 13th. Two analysts have rated the stock with a Strong Buy rating. According to MarketBeat.com, Terumo currently has an average rating of “Strong Buy”.

Get Our Latest Analysis on Terumo

Terumo Trading Up 2.5%

OTCMKTS:TRUMY traded up $0.37 during trading hours on Friday, hitting $15.05. 462,979 shares of the company were exchanged, compared to its average volume of 173,876. The stock has a market capitalization of $22.20 billion, a price-to-earnings ratio of 31.35 and a beta of 0.82. Terumo has a one year low of $12.08 and a one year high of $16.81. The company has a fifty day simple moving average of $14.80 and a 200 day simple moving average of $14.09. The company has a current ratio of 2.19, a quick ratio of 1.37 and a debt-to-equity ratio of 0.13.

Terumo (OTCMKTS:TRUMY – Get Free Report) last released its quarterly earnings results on Thursday, November 12th. The company reported ($0.07) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.06). The company had revenue of $1.96 billion during the quarter, compared to the consensus estimate of $1.94 billion. Terumo had a net margin of 9.31% and a return on equity of 7.03%. Sell-side analysts expect that Terumo will post 0.86 EPS for the current fiscal year.

About Terumo

(Get Free Report)

Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services. Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.

See Also

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.